Eighteen GN cases (58%) remained without a genetic diagnosis (Figure 1), which included a screening of the SPAST, SPG11, SPG7, MFN2, MPZ, KIF5A, and GJB1 genes for structural variants. This evidence concerns the gene SPAST and ganglioneuroma.